醫學生物學研究領域 2013

Chang, Tse Wen

  • Chen NY, Hung AF, Lin CJ, Chen JB, Chu HM, Yu HM, Chang HY, Chang TW, 2013, “Manipulating mIgD-expressing B cells with anti-migis-delta monoclonal antibodies.”, Molecular immunology, 53(3), 187-197. (SCIE) (IF: 3.641; SCIE ranking: 39.7%,45.3%)

Chen, Chien-Jen

  • Lo YL, Hsiao CF, Chang GC, Tsai YH, Chen YM, Huang MS, Su WC, Chen YM, Hsin CW, Chang CH, Yang PC, Chen CJ, Hsiung CA, 2013, “Risk factors for primary lung cancer among never smokers by gender in a matched case-control study”, Cancer Cause Control, 24(3), 567-576. (SCIE) (IF: 2.375; SCIE ranking: 72.1%,40.4%)
  • Yang SY, Yang TY, Li YJ, Chen KC, Liao KM, Hsu KH, Tsai CR, Chen CY, Hsu CP, Hsia JY, Chunag CY,Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Hsiung CA,Shen CY, Yang PC, Chang GC*, Chen CJ*, 2013, “EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients”, Int J Cancer, 132, 449-458. (SCIE) (IF: 5.145; SCIE ranking: 24.2%)
  • Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, Wang LY, You SL, Hsiao CK, Yang HI, Chen CJ* for the REVEAL-HBV Study Group, 2013, “A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection”, J Hepatol, 58(5), 853-860. (SCIE) (IF: 20.582; SCIE ranking: 2.3%)
  • Chen Y, Copeland WK, Vedanthan R, Grant E, Lee JE, Gu D, Gupta PC, Ramadas K, Inoue M, Tsugane S, Tamakoshi A, Gao YT, Yuan JM, Shu XO, Ozasa K, Tsuji I, Kakizaki M, Tanaka H, Nishino Y, Chen CJ, Wang R, Yoo KY, Ahn YO, Ahsan H, Pan WH, Chen CS, Pednekar MS, Sauvaget C, Sasazuki S, Yang G, Koh WP, Xiang YB, Ohishi W, Watanabe T, Sugawara Y, Matsuo K, You SL, Park SK, Kim DH, Parvez F, Chuang SY, Ge W, Rolland B, McLerran D, Sinha R, Thornquist M, Kang D, Feng Z, Boffetta P, Zheng W, He J, Potter JD, 2013, “Association between body mass index and cardiovascular disease mortality east Asians and south Asians: pooled analysis ofprospective data from Asia Cohort Consortium”, Brit Med J, 347, f5446.
  • Chiang CH, Yang HI, Jen CL, Lu SN, Wang LY, You SL, Su J, Iloeje UH, Chen CJ*, 2013, “Association between obesity, hypertriglyceridemia and low hepatitis B viral load”, Int J Obesity, 37, 410-415. (SCIE) (IF: 4.419; SCIE ranking: 20.3%,20.2%)
  • Lin Y, Fu R, Grant E, Chen Y, Lee JE,Gupta PC, Ramadas K, Inoue M, Tsugane S, Gao YT, Tamakoshi A, Shu XO, Ozasa K, Tsuji I, Kakizaki M, Tanaka H, Chen CJ, Yoo KY, Ahn YO, Ahsan H, Pednekar MS, Sauvaget C, Sasazuki S, Yang G, Xiang YB, Ohishi W, Watanabe T, Nishino Y, Suzuki T, You SL, Park SK, Kim DH, Parvez F, Rolland B, McLerran D, Sinha R, Boffetta P, Zheng W, Thornquist M,Feng Z, Kang D, Potter JD, 2013, “Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium”, Eur J Cancer Prev, 22(3), 244-250. (SCIE) (IF: 2.413; SCIE ranking: 70.5%)
  • Chang C, Middeldorp J, Yu KJ, Juwana H, Hsu WL, Lou PJ, Wang CP, Chen JY, Liu MY, Pfeiffer RM, Chen CJ, Hildesheim A, 2013, “Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma”, J Med Virol, 85(3), 524-529. (SCIE) (IF: 2.021; SCIE ranking: 75.7%)
  • Chang CH, Hsiao CF, Yeh YM, Chang GC, Tsai YH, Chen YM, Huang MS, Chen HL, Li YJ, Yang PC, Chen CJ, Hsiung CA, Su WC, 2013, “Circulating interleukin-6 level is a prognostic marker for survival in advanced non-small cell lung cancer patients treated with chemotherapy”, International Journal of Cancer, 132(9), 1977-1985. (SCIE) (IF: 5.145; SCIE ranking: 24.2%)
  • Wang YH, Yeh SD, Wu MM, Liu CT, Shen CH, Shen KH, Pu YS, Hsu LI, Chiou HY, Chen CJ, 2013, “Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer”, Journal of Hazardous Materials, 262, 1139-1146. (SCIE) (IF: 9.038; SCIE ranking: 7.5%,3%)
  • Hwang LC*, Bai CH, You SL, SunCA, Chen CJ, 2013, “Description and prediction of the development of metabolic syndrome: a longitudinal analysis using a Markov model approach”, PLoS One, 8(6), e67436. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Chen YM, Huang MS, Hsiung CA, Chen CJ, Yang PC*, GELAC Study Group, 2013, “EGFR polymorphisms, hormone replacement therapy, and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women”, Carcinogenesis, 34(3), 612-619. (SCIE) (IF: 4.603; SCIE ranking: 31.6%)
  • Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM*, 2013, “Global DNA methylation in a population with aflatoxin B1 Exposure”, Epigenetics, 8(9), 962-969. (SCIE) (IF: 4.251; SCIE ranking: 23%,29%)
  • Cheng HR, Liu CJ, Tseng TC, Su TH, Yang HI, Chen CJ, Kao JH*, 2013, “Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients”, PLoS One, 8(1), e53008. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Hsu LI, Chen CJ, 2013, “Hsu and Chen respond to “implication for prevention and future research””, Am J Epidemiol, 177(3), 217-218. (SCIE) (IF: 4.526; SCIE ranking: 11.9%)
  • Chang YJ, Chen HC, Pan MH, Lee BH, You SL, Lin CY, Chou YC, Hsieh CY, Cheng YJ, Liaw KL, Hsing AW, Schiffman M, Chen CJ*, for CBCSP-HPV Study Group, 2013, “Intratypic variants of human papillomavirus types 16 and risk of cervical neoplasia in Taiwan”, J Med Virol, 85, 1567-1576. (SCIE) (IF: 2.021; SCIE ranking: 75.7%)
  • Yang TY, Hsu LI, Chen HC, Chiou HY, Hsueh YM, Wu MM, Chen CL, Wang YH, Liao YT, Chen CJ*, 2013, “Lifetime risk of urothelial carcinoma and lung cancer in the arseniasis-endemic area of northeastern Taiwan”, Journal of Asian Earth Sciences, 77, 332-337. (SCIE) (IF: 3.059; SCIE ranking: 27%)
  • Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ* for the R.E.V.E.A.L.-HBV Study Group, 2013, “Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients”, PLoS One, 8(4), e61448. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ* for the R.E.V.E.A.L.-HBV Study Group, 2013, “Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles”, Hepatology, 58(2), 546-554. (SCIE) (IF: 14.679; SCIE ranking: 6.8%)
  • Loomba R, Yang HI, Su J, Brenner D, Barrett-Connor E, Iloeje U, Chen CJ, 2013, “Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study”, Am J Epidemiol, 177, 333-342. (SCIE) (IF: 4.526; SCIE ranking: 11.9%)
  • Loomba R*, Liu J, Yang HI*, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ for the R.E.V.E.A.L.-HBV Study Group, 2013, “Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma”, Clinical Gastroenterology and Hepatology, 11(12), 1636-1645.e3. (SCIE) (IF: 8.549; SCIE ranking: 11.4%)
  • LI Hsu; YH Wang; HY Chiou; MM Wu; TY Yang; YH Chen; CH Tseng; CJ Chen, 2013, “The association of diabetes mellitus with subsequent internal cancers in the arsenic-exposed area of Taiwan”, J Asian Earth Sci, 73, 452-459. (SCIE) (IF: 3.059; SCIE ranking: 27%)
  • Chiang CJ, Yang YW, You SL, Lai MS, Chen CJ*, 2013, “Thirty-year outcomes of the national hepatitis B immunization program in Taiwan”, JAMA-J Am Med Assoc, 310(9), 974-976. (SCIE) (IF: 45.54; SCIE ranking: 1.8%)
  • Chung CJ, Huang YL, Huang YK, Wu Meei-Maan, Chen SY, Hsueh YM*, Chen CJ, 2013, “Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan”, Environ Res, 122, 25-30. (SCIE) (IF: 5.715; SCIE ranking: 7.8%,11.7%)
  • Hsu LI, Chen GS, Lee CH, Yang TY, Chen YH, Wang YH, Hsueh YM, Chiou HY, Wu MM, Chen CJ*, 2013, “Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy”, Am J Epidemiol, 177, 202-212. (SCIE) (IF: 4.526; SCIE ranking: 11.9%)

Hsiao, Michael

  • Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM, 2013, “A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.”, Carcinogenesis, 34(12), 2918-2928. Cite 14. (SCIE) (IF: 4.603; SCIE ranking: 31.6%)
  • Chen MH, Jan YH, Chang PM, Chuang YJ, Yeh YC, Lei HJ, Hsiao M, Huang SF, Huang CY, Chau GY, 2013, “Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma”, Ann Surg Oncol, 20(Suppl 3), S616-S624. Cite 7. (SCIE) (IF: 4.061; SCIE ranking: 11.9%,35.7%)
  • Cheng HC, Liu YP, Shan YS, Huang CY, Lin FC, Lin LC, Lee L, Tsai CH, Hsiao M*, Lu PJ, 2013, “Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.”, Carcinogenesis, 34(11), 2452-2459. Cite 6. (SCIE) (IF: 4.603; SCIE ranking: 31.6%)
  • Lee YC, Que J, Chen YC, Lin JT, Liou YC, Liao PC, Liu YP, Lee KH, Lin LC, Hsiao M, Hung LY, Huang CY, Lu PJ, 2013, “Pin1 acts as a negative regulator of the G2/M transition through an interplay with the Aurora A/hBora complex.”, J Cell Sci, 126(21), 4862-4872. Cite 4. (SCIE) (IF: 4.573; SCIE ranking: 33.3%)
  • Hu YF, Chen TC, Chau GY, Yang TL, Liu CJ, Chen MH, Chang PM, Chen TJ, Hsiao M, Huang CY, Chen SA, 2013, “Baseline hypertension: New insight into the potential predictors of survival in patients with hepatocellular carcinoma.”, Int J Cardiol, 168(3), 2979-2981. Cite 2. (SCIE) (IF: 3.229; SCIE ranking: 39.9%)
  • Liu YP, Liao WC, Ger LP, Chen JC, Hsu TI, Lee YC, Chang HT, Chen YC, Jan YH, Lee KH, Zeng YH, Hsiao M*, Lu PJ, 2013, “Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer.”, Cancer Research, 73(20), 6194-6205. Cite 13. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Tsai HY, Yang YF, Wu AT, Yang CJ, Liu YP, Jan YH, Lee CH, Hsiao YW, Yeh CT, Shen CN, Lu PJ, Huang MS, Hsiao M*, 2013, “Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.”, Oncogene, 32(41), 4921-4931. Cite 40. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Hsiao PC, Hsieh YH, Chow JM, Yang SF, Hsiao M, Hua KT, Lin CH, Chen HY, Chien MH, 2013, “Hispolon Induces Apoptosis through JNK1/2-mediated Activation of a Caspase-8, -9, and -3-dependent Pathway in Acute Myeloid Leukemia (AML) Cells and Inhibits AML Xenograft Tumor Growth in Vivo.”, J Agric Food Chem, 61(42), 10063-10073. Cite 11.
  • Cheng WH, Ho WY, Chang CF, Lu PJ, Cheng PW, Yeh TC, Hong LZ, Sun GC, Hsiao M, Tseng CJ, 2013, “Simvastatin induces a central hypotension effect via ras-mediated signaling to integrate eNOS upregulation”, Brit J Pharmacol, 170(4), 847-858. Cite 6. (SCIE) (IF: 7.73; SCIE ranking: 3.3%)
  • Wang CH, Ma N, Lin YT, Wu CC, Wu HJ, Yu CC, Hsiao M, Lu FL, Schuyler SC, Lu J, 2013, “Array-based high throughput screen in mouse embryonic stem cells with shRNAs”, Curr Protoc Stem Cell Biol, Sep. 20;26:5C.3.1-19..
  • Lin YF, Lai TC, Chang CK, Chen CL, Huang MS, Yang CJ, Liu HG, Dong JJ, Chou YA, Teng KH, Chen SH, Tian WT, Jan YH, Hsiao M, Liang PH, 2013, “Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies.”, J Clin Invest, 123(9), 3861-3875. Cite 6. (SCIE) (IF: 11.864; SCIE ranking: 2.2%)
  • Yeh CT, Su CL, Huang CY, Lin JK, Lee WH, Chang PM, Kuo YL, Liu YW, Wang LS, Wu CH, Shieh YS, Jan YH, Chuang YJ, Hsiao M, Wu AT, 2013, “A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agent.”, Evid Based Complement Alternat Med, 2013, 910451. Cite 1.
  • Lee CM, Su YH, Huynh TT, Lee WH, Chiou JF, Lin YK, Hsiao M, Wu CH, Lin YF, Wu AT, Yeh CT, 2013, “Blueberry isolate, pterostilbene, functions as a potential anticancer stem cell agent in suppressing irradiation-mediated enrichment of hepatoma stem cells”, Evid Based Complement Alternat Med, 2013, 258425. Cite 2.
  • Chien MH, Lee LM, Hsiao M, Wei LH, Chen CH, Lai TC, Hua KT, Chen MW, Sun CM, Kuo ML, 2013, “Inhibition of metastatic potential in breast carcinoma in vivo and in vitro through targeting VEGFRs and FGFRs.”, Evid Based Complement Alternat Med, 2013, 718380. Cite 1.
  • Liu YP, Hsiao M*, 2013, “Exercise-induced SPARC prevents tumorigenesis of colon cancer”, Gut, 62(6), 810-811. Cite 7. (SCIE) (IF: 19.819; SCIE ranking: 3.4%)
  • Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M*, Huang CY, 2013, “An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.”, Mol Cel Proteomics, 12(5), 1335-1349. Cite 22. (SCIE) (IF: 4.87; SCIE ranking: 10.4%)
  • Lu WH, Hsieh KS, Lu PJ, Wu YS, Ho WY, Lai CC, Wang JS, Ger LP, Hsiao M, Tseng CJ, 2013, “Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis.”, Crit Care Med, 41(5), 1276-1285. Cite 4. (SCIE) (IF: 7.414; SCIE ranking: 13.9%)
  • Cheng LC, Chen HM, Lai TC, Liu RS, Sung JC, Hsiao M*, Chen CH, Her LJ, Tsai DP, 2013, “Targeting polymeric fluorescent nanodiamond-gold/silver multi-functional nanoparticles as a light-transforming hyperthermia reagent for cancer cell”, Nanoscale, May 7;5(9):3931-40. Cite 38. (SCIE) (IF: 6.895; SCIE ranking: 15.8%,24.3%,14.8%,15.9%)
  • Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW, Jeng YM, Chiou J, Yu P, Chen PS, Wang MY, Hsiao M, Su JL, Kuo ML, 2013, “Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.”, J Clin Invest, 123(3), 1082-1095. Cite 18. (SCIE) (IF: 11.864; SCIE ranking: 2.2%)
  • Chang CC, Yang MH, Lin BR, Chen ST, Pan SH, Hsiao M, Lai TC, Lin SK, Jeng YM, Chu CY, Chen RH, Yang PC, Eugene Chin Y, Kuo ML, 2013, “CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.”, Cell Death Differ, 20(3), 443-455. Cite 7. (SCIE) (IF: 10.717; SCIE ranking: 8.7%,6.4%)
  • Lee YC, Liao PC, Liou YC, Hsiao M, Huang CY, Lu PJ, 2013, “Glycogen synthase kinase 3 beta activity is required for hBora/Aurora A-mediated mitotic entry.”, Cell Cycle, 12(6), 953-960. Cite 6. (SCIE) (IF: 3.699; SCIE ranking: 49.2%)
  • Chen Z, Lai TC, Jan YH, Lin FM, Wang WC, Xiao H, Wang YT, Sun W, Cui X, Li YS, Fang T, Zhao H, Padmanabhan C, Sun R, Wang DL, Jin H, Chau GY, Huang HD, Hsiao M, Shyy JY, 2013, “Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis”, J Clin Invest, 123(3), 1057-1067. Cite 38. (SCIE) (IF: 11.864; SCIE ranking: 2.2%)
  • Kok SH, Lin LD, Hou KL, Hong CY, Chang CC, Hsiao M, Wang JH, Lai EH, Lin SK, 2013, “Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling.”, Arthritis Rheum, 65(3), 639-649. Cite 12.
  • Baginsky I, Lai TC, Cheng LC, Yang KY, Liu RS, Hsiao M*, Chen CH, Hu SF, Her LJ, Tsai DP, 2013, “Chitosan-modified stable colloidal gold nanostars for the photothermolysis of cancer cells”, J Phys Chem C, 117, 2396-2410. Cite 19. (SCIE) (IF: 4.189; SCIE ranking: 42.7%,35.8%,28.7%)
  • Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M*, 2013, “Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling”, Cancer Research, 73(1), 406-416. Cite 129. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Chen MH, Yeh YC, Shyr YM, Jan YH, Chao Y, Li CP, Wang SE, Tzeng CH, Chang PM, Liu CY, Chen MH, Hsiao M*, Huang CY, 2013, “Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors”, J Gastroenterol, 48(1), 101-108. Cite 6. (SCIE) (IF: 6.132; SCIE ranking: 19.3%)
  • Chen CY, Jan YH, Juan YH, Yu CJ, Yang CJ, Huang MS, Yang PC, Hsiao M, Hsu TL, Wong CH, 2013, “Fucosyltransferase 8 as a functional regulator of non-small cell lung cancer”, Proc Natl Acad Sci USA, 110(2), 630-635. Cite 29.
  • Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW, Chen YH, Jan Y, Hsiao M, Chang TY, Liu YH, Jeng YM, Wu CH, Huang MT, Su YH, Hung MC, Chien MH, Chen CY, Kuo ML, Su JL, 2013, “MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol.”, Oncogene, Jan 24;32(4):431-43. Cite 36. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)

Hsieh, Shie-Liang

  • Hsu TL, Lin G, Koizumi A, Brehm K, Hada N, Chuang PK, Wong CH, Hsieh SL, Díaz A., 2013, “The surface carbohydrates of the Echinococcus granulosus larva interact selectively with the rodent Kupffer cell receptor.”, MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 192(1-2), 55-59. (SCIE) (IF: 1.571; SCIE ranking: 63.2%,85.5%)
  • Wu NL, Huang DY, Hsieh SL, Hsiao CH, Lee TA, Lin WW., 2013, “EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.”, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1832(10), 1538-1548. (SCIE) (IF: 4.352; SCIE ranking: 27.6%,19.7%)
  • Yang CY, Chen JB, Tsai TF, Tsai YC, Tsai CY, Liang PH, Hsu TL, Wu CY, Netea MG, Wong CH, Hsieh SL*, 2013, “CLEC4F is an inducible C-type lectin in F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liver.”, PLoS One, 8(6), e65070. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Wu MF, Chen ST, Hsieh SL*, 2013, “Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets.”, JOURNAL OF BIOMEDICAL SCIENCE, 20, 36. (SCIE) (IF: 5.762; SCIE ranking: 24.1%,12.2%)
  • Shu CC, Wu MF, Hsu CL, Huang CT, Wang JY, Hsieh SL, Yu CJ, Lee LN, Yang PC., 2013, “Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction.”, BMC INFECTIOUS DISEASES, 13: 45. (SCIE) (IF: 2.688; SCIE ranking: 46.2%,84.8%)
  • Wu MF, Chen ST, Yang AH, Lin WW, Lin YL, Chen NJ, Tsai IS, Li L, Hsieh SL*, 2013, “CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages”, BLOOD, 121(1), 95-106. (SCIE) (IF: 17.794; SCIE ranking: 1.3%)

Lee, Wen-Hwa

  • Ngo B, Hu CM, Guo XE, Ngo B, Wei R, Zhu J, Lee WH, 2013, “Complementary Interhelical Interactions between Three Buried Glu-Lys Pairs within Three Heptad Repeats Are Essential for Hec1-Nuf2 Heterodimerization and Mitotic Progression.”, The Journal of biological chemistry, 288(48), 34403-34413. (SCIE) (IF: 4.238; SCIE ranking: 29.3%)
  • He S, Ni D, Ma B, Lee JH, Zhang T, Ghozalli I, Pirooz SD, Zhao Z, Bharatham N, Li B, Oh S, Lee WH, Takahashi Y, Wang HG, Minassian A, Feng P, Deretic V, Pepperkok R, Tagaya M, Yoon HS, Liang C, 2013, “PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport by differential interactions with the ER tether and the beclin 1 complex.”, Nature cell biology, 15(10), 1206-1219. (SCIE) (IF: 20.042; SCIE ranking: 4.1%)
  • Yi-Cheng Chang, Yu-Hsiang Yu, Jin-Yuh Shew ,Wei-Jei Lee, Juey-Jen Hwang, Yen-Hui Chen, Yet-Ran Chen, Pei-Chi Wei, Lee-Ming Chuang, Wen-Hwa Lee*., 2013, “Deficiency of NPGPx, an oxidative stress sensor, leads to obesity in mice and human.”, EMBO Molecular Medicine, 5(8), 1165-1179. (SCIE) (IF: 8.821; SCIE ranking: 6.5%)
  • Lin LF, Li CF, Wang WJ, Yang WM, Wang DD, Chang WC, Lee WH, Wang JM. , 2013, “Loss of ZBRK1 Contributes to the Increase of KAP1 and Promotes KAP1-Mediated Metastasis and Invasion in Cervical Cancer ”, PLoS One, 8(8), e73033. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Wendy W. Hwang-Verslues, Po-Hao Chang, Yung-Ming Jeng, Wen-Hung Kuo, Pei-Hsun Chiang, Yi-Cheng Chang, Tsung-Han Hsieh, Fang-Yi Su, Liu-Chen Lin, Serena Abbondante, Cheng-Yuan Yang, Huan-Ming Hsu, Jyh-Cherng Yu, King-Jen Chang, Jin-Yuh Shew, Eva Y.-H. P. Lee, Wen-Hwa Lee*., 2013, “Loss of corepressor PER2 under hypoxia upregulates OCT1-mediated EMT gene expression and enhances tumor malignancy.”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(30), 12331-12336. (SCIE) (IF: 9.412; SCIE ranking: 11.3%)
  • Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E, Bhatia R, Chamberlin AR, Chen PL, Lee WH, 2013, “A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia.”, EMBO molecular medicine, 5(3), 353-365. (SCIE) (IF: 8.821; SCIE ranking: 6.5%)
  • Wei PC, Wang ZF, Lo WT, Su MI, Shew JY, Chang TC, Lee WH*., 2013, “A cis-element with mixed G-quadruplex structure of NPGPx promoter is essential for nucleolin-mediated transactivation on non-targeting siRNA stress.”, Nucleic acids research, 41(3), 1533-1543. (SCIE) (IF: 11.502; SCIE ranking: 5.1%)

Lin, Kuo-I

  • Liao, S.-F, Liang, C.-H., Ho, M.-Y., Hsu, T.-L., Tsai, T.-I, Hsieh, Y. S.-Y., Tsai, C.-M., Li, S.-T., Cheng, Y.-Y., Tsao, S.-M., Lin, T.-Y., Lin, Z.-Y. , Yang, W.-B., Ren, C.-T., Lin, K.-I, Khoo, K.-H., Lin, C.-H., Hsu, H.-Y., Wu, C.-Y., and Wong, C.-H., 2013, “Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(34), 13809-13814. (SCIE) (IF: 9.412; SCIE ranking: 11.3%)
  • Huang, H.-W., Chen, C.-H., Lin, C.-H., Wong, C.-H.*, and Lin, K.-I*, 2013, “B cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(27), 10928-10933. (SCIE) (IF: 9.412; SCIE ranking: 11.3%)
  • Tu, Z., Hsieh, H.-W., Tsai, C.-M., Hsu, C.-W., Wang, S.-G., Wu, K.-J., Lin, K.-I*, and Lin, C.-H*, 2013, “Synthesis and characterization of sulfated Gal-beta-1, 3/4-GlcNAc disaccharides via consecutive Protection/glycosylation steps”, Chemistry-An Asian Journal, 8 (7), 1536-1550. (SCIE) (IF: 4.056; SCIE ranking: 30.5%)
  • Wang, S.-H., Tsai, C.-M., Lin, K.-I* and Khoo, K.-H.*, 2013, “Advanced mass spectrometry and chemical analyses reveal the presence of terminal disialyl motif on mouse B-cell glycoproteins”, GLYCOBIOLOGY, 23(6), 677-689. (SCIE) (IF: 4.06; SCIE ranking: 34.3%)
  • Chiang, M.-F., Yang, S.-Y., Lin, I-Y., Hong, J.-B., Lin, S.-J., Ying, H.-Y., Chen, C.-M., Wu, S.-Y., Liu, F.-T., and Lin, K.-I*, 2013, “ Inducible deletion of Blimp-1 gene in adult epidermis causes granulocyte-dominated chronic skin inflammation in mice”, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(16), 6476-6481. (SCIE) (IF: 9.412; SCIE ranking: 11.3%)
  • Lin, M.-H., Chou, F.-F., Yeh, L.-T., Fu, S.-H., Chiou, H.-Y., Lin, K.-I, Chang, D.-M. and Sytwu H.-K., 2013, “B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells”, DIABETOLOGIA, 56(1), 136-146. (SCIE) (IF: 7.518; SCIE ranking: 7%)

Lu, Joyce Jean

  • Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M, 2013, “Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling.”, Cancer Research, 73(1), 406-416. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)
  • Chen HW, Chen HY, Wang LT, Wang FH, Fang LW, Lai HY, Chen HH, Lu J, Hung MS, Cheng Y, Chen MY, Liu SJ, Chong P, Lee OK, Hsu SC, 2013, “Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines.”, Journal of Immunology, 190(10), 5065-5077. (SCIE) (IF: 4.886; SCIE ranking: 28.3%)
  • Lu FL, Yu CC, Chiu HH, Liu HE, Chen SY, Lin S, Goh TY, Hsu HC, Chien CH, Wu HC, Chen MS, Schuyler SC, Hsieh WS, Wu MH, Lu J*, 2013, “Sonic hedgehog antagonists induce cell death in acute myeloid leukemia cells with the presence of lipopolysaccharides, tumor necrosis factor-alpha, or interferons.”, Investigational New Drugs, 31(4), 823-832. (SCIE) (IF: 3.525; SCIE ranking: 44.7%,29.5%)
  • Wang CH, Ma N, Lin YT, Wu CC, Wu HJ, Yu CC, Hsiao M, Lu FL, Schuyler SC, and Lu, J*, 2013, “UNIT 5C.3 Array-based high-throughput screening in mouse embryonic stem cells with shRNAs”, Current Protocols in Stem Cell Biology, 26: 5C.3.1-5C. 3.19.

Shen, Chia-Ning

  • Tsai HY, Yang YF, Wu AT, Yang CJ, Liu YP, Jan YH, Lee CH, Hsiao YW, Yeh CT, Shen CN, Lu PJ, Huang MS, Hsiao M, 2013, “Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78.”, Oncogene, 32(41), 4921-4931. (SCIE) (IF: 7.971; SCIE ranking: 15.9%,7.9%,9.8%,10.7%)
  • Lin YH, Chang HM, Chang FP, Shen CR, Liu CL, Mao WY, Lin CC, Lee HS, Shen CN*, 2013, “Protoporphyrin IX accumulation disrupts mitochondrial dynamics and function in ABCG2-deficient hepatocytes.”, FEBS letters, 587(19), 3202-3209. (SCIE) (IF: 3.057; SCIE ranking: 51.9%,62.6%,33.8%)
  • 沈家寧,2013,《您不可不知道的幹細胞科技》,共208頁,台北市:五南圖書出版有限公司。
  • WY Liao, CC Liaw, YC Huang, HY Han, HW Hsu, SM Hwang, SC Kuo and CN Shen*, 2013, “Cyclohexylmethyl flavonoids suppress propagation of breast cancer stem cells via downregulation of NANOG”, Evidence-based Complementary and Alternative Medicine, 2013, 170261. (SCIE) (IF: 1.813; SCIE ranking: 57.1%)
  • Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M, 2013, “Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.”, Cancer Research, 73(1), 406-416. (SCIE) (IF: 9.727; SCIE ranking: 7.8%)

Yang, Hwai-I

  • Liu J, Lee MH, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, Wang LY, You SL, Hsiao CK, Yang HI, Chen CJ, 2013, “A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.”, JOURNAL OF HEPATOLOGY, 58(5), 853-860. (SCIE) (IF: 20.582; SCIE ranking: 2.3%)
  • Loomba R, Yang HI, Chen CJ, 2013, “Author reply.”, American journal of epidemiology, 178(6), 1011-1012. (SCIE) (IF: 4.526; SCIE ranking: 11.9%)
  • Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM, 2013, “Global DNA methylation in a population with aflatoxin B1 exposure.”, Epigenetics, 8(9), 962-969. (SCIE) (IF: 4.251; SCIE ranking: 23%,29%)
  • Cheng HR, Liu CJ, Tseng TC, Su TH, Yang HI, Chen CJ, Kao JH, 2013, “Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.”, PLoS One, 8(1), e53008. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lin YJ, Lee MH, Yang HI, Jen CL, You SL, Wang LY, Lu SN, Liu J, Chen CJ, 2013, “Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.”, PLoS One, 8(4), e61448. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lee MH, Yang HI, Liu J, Batrla-Utermann R, Jen CL, Iloeje UH, Lu SN, You SL, Wang LY, Chen CJ, 2013, “Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles.”, HEPATOLOGY, 58(2), 546-554. (SCIE) (IF: 14.679; SCIE ranking: 6.8%)
  • Yen TA, Yang HI, Hsieh WS, Chou HC, Chen CY, Tsou KI, Tsao PN, 2013, “Preeclampsia and the Risk of Bronchopulmonary Dysplasia in VLBW Infants: A Population Based Study.”, PloS one, 8(9), e75168. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Lin PH, Lin CC, Yang HI, Li LY, Bai LY, Chiu CF, Liao YM, Lin CY, Hsieh CY, Lin CY, Ho CM, Yang SF, Peng CT, Tsai FJ, Yeh SP, 2013, “Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3.”, LEUKEMIA RESEARCH, 37(3), 287-292. (SCIE) (IF: 2.214; SCIE ranking: 67.1%,77%)
  • Loomba R*, Yang HI*, Su J, Brenner D, Barrett-Connor E, Iloeje U, Chen CJ, 2013, “Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.”, AMERICAN JOURNAL OF EPIDEMIOLOGY, 177(4), 333-342. (SCIE) (IF: 4.526; SCIE ranking: 11.9%)
  • Loomba R*, Liu J, Yang HI*, Lee MH, Lu SN, Wang LY, Iloeje UH, You SL, Brenner D, Chen CJ, 2013, “Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.”, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(12), 1636-1645.e1-3. (SCIE) (IF: 8.549; SCIE ranking: 11.4%)

Yu, Alice Lin-Tsing

  • Huang YL, Hung JT, Cheung SK, Lee HY, Chu KC, Li ST, Lin YC, Ren CT, Cheng TJ, Hsu TL, Yu AL, Wu CY, Wong CH, 2013, “Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer.”, Proceedings of the National Academy of Sciences of the United States of America, 110(7), 2517-2522. (SCIE) (IF: 9.412; SCIE ranking: 11.3%)
  • Chan YT, Lin YC, Lin RJ, Kuo HH, Thang WC, Chiu KP, Yu AL, 2013, “Concordant and discordant regulation of target genes by miR-31 and its isoforms.”, PloS one, 8(3) ,e58169. (SCIE) (IF: 2.74; SCIE ranking: 38%)
  • Unguru Y, Joffe S, Fernandez CV, Yu AL, 2013, “Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.”, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(5), 641-646. (SCIE) (IF: 32.956; SCIE ranking: 2%)
  • Chang WW, Lin RJ, Yu J, Chang WY, Fu CH, Lai AC, Yu JC, Yu AL, 2013, “The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.”, Breast cancer research : BCR, 15(3), R39. (SCIE) (IF: 4.988; SCIE ranking: 26.2%)

論文集